← Leaderboards
Salim Hayek
University Of Michigan At Ann Arbor
$3,679,918
Attributed
$3,679,918
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $874.4K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,679,918 · 3
By mechanism
R01$2,872,742 · 2
U54$807,176 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Suzanne E Judd$21,734,940
- Theodore S Lawrence$30,022,406
- Yan Sun$7,090,899
- David J. Pinsky$32,329,328
- Celina G Kleer$13,464,529
Others in their field
Other Emerging Leaders on “Kidney”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Barbara Halina Braffett · George Washington University$18,816,779
- Ionut Bebu · George Washington University$18,816,779
- Noel P Burtt · Broad Institute, Inc.$12,561,765
Research focus
KidneyRenal FunctionPathway InteractionsBiological MarkersKidney DiseasesChronic Kidney FailureLinkFollow-UpMultidisciplinaryDesignCohortSamplingEtiologyData SetUnited StatesPlacebosPreventMembraneRandomizedCytokineInjury To KidneyKidney DysfunctionExperimental ModelsFunctional Disorder
Grant awards (9)
Resource Development Core$264,392
U54 · FY2025 · DK · contact PI
Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease$439,526
R01 · FY2024 · HL · contact PI
Resource Development Core$264,392
U54 · FY2024 · DK · contact PI
Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease$474,300
R01 · FY2023 · HL · contact PI
Resource Development Core$278,392
U54 · FY2023 · DK · contact PI
Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease$548,190
R01 · FY2022 · HL · contact PI
Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease$547,647
R01 · FY2021 · HL · contact PI
Extracorporeal SuPAR Extraction to Prevent COVID-19-associated Acute Kidney Injury$326,710
R01 · FY2021 · DK · contact PI
Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease$536,369
R01 · FY2020 · HL · contact PI